ORIGINAL PAPER
Treatment of the acute severe pulmonary embolism using endovascular methods
More details
Hide details
Submission date: 2018-03-28
Final revision date: 2018-04-12
Acceptance date: 2018-04-16
Publication date: 2018-06-01
Pol J Radiol, 2018; 83: 248-252
KEYWORDS
TOPICS
ABSTRACT
Purpose:
To present a single-centre experience with endovascular treatment of patients with severe symptoms secondary to acute pulmonary embolism (PE).
Material and methods:
Twenty-five patients were treated due to contraindications or deficient effects of systemic thrombolytic therapy. The patients were treated with a combination of fragmentation and aspiration, only aspiration, or only fragmentation, and with catheter-directed thrombolytic therapy.
Results:
The saturation was improved following treatment in all patients, except in one where the procedure could not be completed. There were no immediate or late procedure-related complications.
Conclusions:
Endovascular treatment of severe PE is a safe and efficient option in patients with failing effect or contraindication to systemic thrombolysis.
REFERENCES (24)
1.
Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121: 877-905.
2.
Perrier A, Roy PM, Sanchez O, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005; 352: 1760-1768.
3.
Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005; 165: 1777-1781.
4.
Ten Wolde M, Söhne M, Quak E, et al. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 2004; 164: 1685-1689.
5.
Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: The seventh ACCP conference on antithrombotic and thrombolytic therpy. Chest 2004; 126: 401-428.
6.
Dumantepe M, Teymen B, Akturk U, et al. Efficacy of rotational thrombectomy on the mortality of patients with massive and submassive pulmonary embolism. J Card Surg 2015; 30: 324-332.
7.
Lee MY, Kim MY, Han JY, et al. Pregnancy-associated pulmonary embolism during the peripartum period: An 8-year experience at a single center. Obstet Gynecol Sci 2014; 57: 260-265.
8.
Bayiz H, Dumantepe M, Teymen B, et al. Percutaneous aspiration thrombectomy in treatment of massive pulmonary embolism. Heart Lung Circ 2015; 24: 46-54.
9.
Pelliccia F, Schiariti M, Terzano C, et al. Treatment of acute pulmonary embolism: update on newer pharmacologic and interventional strategies. Biomed Res Int 2014; 2014: 410341.
10.
Mohan B, Aslam N, Kumar Mehra A, et al. Impact of catheter fragmentation followed by local intrapulmonary thrombolysis in acute high risk pulmonary embolism as primary therapy. Indian Heart J 2014; 66: 294-301.
11.
Garcia MJ. Endovascular Management of Acute Pulmonary Embolism Using the Ultrasound-Enhanced EkoSonic System. Semin Intervent Radiol 2015; 32: 384-387.
12.
Lin PH, Chen H, Bechara CF, et al. Endovascular interventions for Acute Pulmonary Embolism. Perspect Vasc Surg Endovasc Ther 2010; 22: 171-182.
13.
Mostafa A, Briasoulis A, Telila T, et al. Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis. Am J Cardiol 2016; 117: 1014-1020.
14.
Fava M, Loyola S, Flores P, et al. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol 1995; 8: 261-266.
15.
Özsancak Uğurlu A, Çınar Ö, Caymaz İ, et al. Combined catheter thrombus fragmentation and percutaneous thrombectomy in a patient with massive pulmonary emboli and acute cerebral infarct. Anadolu Kardiyol Derg 2015; 15: 72-74.
16.
Kucher N, Boekstegers P, Müller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129: 479-486.
17.
Sag S, Nas OF, Kaderli AA. Catheter-directed ultrasound-accelerated thrombolysis may be life-saving in patients with massive pulmonary embolism after failed systemic thrombolysis. J Thromb Thrombolysis 2016; 42: 322-328.
18.
Bloomer TL, El-Hayek GE, McDaniel MC. Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: results of a multicenter registry and meta-analysis. Catheter Cardiovasc Interv 2017; 89: 754-760.
19.
Mohan PP, Manov JJ, Contreras F, et al. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism. Vasc Endovascular Surg 2018; 52: 195-201.
20.
Trerotola SO, Vesely TM, Lund GB, et al. Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial. Radiology 1998; 206: 403-414.
21.
Goldhaber SZ, Visani L, De Rosa M, et al. Acute Pulmonary Embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Register (ICOPER). Lancet 1999; 353: 1386-1389.
22.
Limbrey R, Howard L. Developments in the management and treatment of pulmonary embolism. Eur Respir Rev 2015; 24: 484-497.
23.
Shatsky JB, Berns JS, Clark TW, et al. Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas. J Vasc Interv Radiol 2005; 16: 1605-1611.
24.
Lee KH, Han H, Lee KJ, et al. Mechanical thrombectomy of acute iliofemoral deep vein thrombosis with use of an Arrow-Trerotola percutaneous thrombectomy device. J Vasc Interv Radiol 2006; 17: 487-495.